Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 4
2005 13
2006 5
2007 7
2008 11
2009 7
2010 8
2011 8
2012 9
2013 11
2014 5
2015 6
2016 9
2017 7
2018 14
2019 13
2020 12
2021 10
2022 12
2023 17
2024 16
2025 17
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Results by year

Filters applied: . Clear all
Page 1
DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma.
Renouf DJ, Topham JT, Loree JM, Schaeffer DF, Knox JJ, Kavan P, Jonker D, Welch S, Couture F, Lemay F, Tehfe M, Harb M, Aucoin N, Ko YJ, Tang PA, Ramjeesingh R, Meyers BM, Kim CA, Du P, Jia S, Karasinska JM, Gill S, Tu D, O'Callaghan CJ. Renouf DJ, et al. Among authors: tu d. Nat Commun. 2026 Mar 7;17(1):3631. doi: 10.1038/s41467-026-70120-z. Nat Commun. 2026. PMID: 41794844 Free PMC article. Clinical Trial.
Effects of a structured exercise program on motivational outcomes in patients with Colon cancer.
Courneya KS, Booth CM, Vardy JL, Friedenreich CM, Dhillon HM, Coyle V, Campbell KL, Arthuso FZ, Turner J, Kent DE, Russell C, Gordon JJ, Henson J, Chua NS, Jonker DJ, Kay S, Gill S, O'Brien P, Tu D, O'Callaghan CJ. Courneya KS, et al. Among authors: tu d. J Natl Cancer Inst. 2026 Jan 29:djag023. doi: 10.1093/jnci/djag023. Online ahead of print. J Natl Cancer Inst. 2026. PMID: 41609410
Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial.
Kim SI, Kim JW, Kwon JS, Ferguson SE, Sebastianelli A, Bessette P, Mahner S, Gauthier T, de Kroon C, van Driel W, Williamson K, Goffin F, Polterauer S, Eyjólfsdóttir B, Lee JY, Maguire PJ, Juhasz-Böss I, Lim H, Seol A, Shepherd L, Tu D, Plante M. Kim SI, et al. Among authors: tu d. Gynecol Oncol. 2026 Feb;205:37-45. doi: 10.1016/j.ygyno.2026.01.001. Epub 2026 Jan 10. Gynecol Oncol. 2026. PMID: 41520567 Free article. Clinical Trial.
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials.
Amdal CD, Falk RS, Alanya A, Schlichting M, Roychoudhury S, Bhatnagar V, Wintner LM, Regnault A, Ingelgård A, Coens C, le Cessie S, Holzner B, Chang J, Taphoorn M, Cislo P, Giesinger JM, Cappelleri JC, Pawar V, Ten Seldam S, Papadopoulos EJ, Calvert MJ, Joseph KL, Bottomley A, Griebsch I, Arraras JI, Astrup GL, Basch E, Belančić A, Brundage M, Campbell A, Rerhou Rantell K, Cocks K, Cherny N, Eremenco S, Ferrer M, Fiero MH, Gerlinger C, Goetghebeur E, Grouven U, Lauer A, Aiyegbusi OL, Machingura A, Mizusawa J, Molenberghs G, Aa Petersen M, Reijneveld JC, Ringash J, Rumpold G, Rutherford C, Quinten C, Sail K, Sasseville M, Sauerbrei W, Schiel A, Smith AW, Snyder C, Velikova G, Wang XS, Bjordal K, Pe M; SISAQOL-IMI Consortium. Amdal CD, et al. Lancet Oncol. 2025 Dec;26(12):e683-e693. doi: 10.1016/S1470-2045(25)00520-0. Lancet Oncol. 2025. PMID: 41308689 Review.
Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis.
Bregni G, Leurquin B, Giasafaki P, Takemura N, Kokudo N, Hasegawa K, Matsuyama Y, Nishioka Y, Aparicio T, Guimbaud R, Malicot KL, Tu D, O'Callaghan C, Lutz MP, Fontana E, Moehler M, Mauer ME, Sclafani F. Bregni G, et al. Among authors: tu d. Eur J Cancer. 2025 Dec 9;231:116092. doi: 10.1016/j.ejca.2025.116092. Epub 2025 Nov 1. Eur J Cancer. 2025. PMID: 41197289
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials.
Coschi CH, Ding K, Tu D, O'Callaghan C, Leighl NB, Vera-Badillo F, Juergens RA, Hao D, Seymour L, Renouf DJ, Chen E, Fung AS, Gaudreau PO. Coschi CH, et al. Among authors: tu d. Immunotherapy. 2025 Oct;17(15):1085-1097. doi: 10.1080/1750743X.2025.2578164. Epub 2025 Nov 1. Immunotherapy. 2025. PMID: 41175109
Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Electronic address: bc.overview@ndph.ox.ac.uk; Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Electronic address: bc.overview@ndph.ox.ac.uk, et al. Lancet. 2025 Aug 9;406(10503):603-614. doi: 10.1016/S0140-6736(25)01013-X. Lancet. 2025. PMID: 40783288 Free article.
203 results